Biohit Oyj (CHIX:BIOBVH) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:BIOBVH Biohit Oyj CHIX:BIOBVH
78 GF Score
Price €2.40
GF Value €2.44
! 3 Warning Signs
View Full Analysis

What is Biohit Oyj Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

CHIX:BIOBVH
78GF Score
Biohit Oyj CHIX:BIOBVH
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Biohit Oyj (CHIX:BIOBVH) Overvalued in 2026?

Based on GuruFocus' analysis, Biohit Oyj stock appears to be undervalued. The current stock price of €2.40 is trading 1.6% below its estimated GF Value™ of €2.44.

Key valuation signals for CHIX:BIOBVH:

  • Dividends Received:
  • GF Value™: €2.44 vs. price of €2.40 (1.6% below fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the CHIX:BIOBVH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biohit Oyj Business Description

Other Exchanges 0DRP:UKBIOBV:Finland
Address Laippatie 1, Helsinki, FIN, 00880
Biohit Oyj is a globally operating Finnish biotechnology company that develops diagnostic and other health products. Its products include GastroPanel quick test assesses the structure and function of the stomach lining; ColonView quick test is an immunochemical fecal occult blood test (FIT) developed; Acetium capsules protect the stomach lining from carcinogenic acetaldehyde, especially in people with acid-free stomachs. The company's product portfolio consists of diagnostic tests, analysis systems, products binding carcinogenic acetaldehyde into a harmless compound and monoclonal antibodies.
78GF Score

Get the complete analysis for CHIX:BIOBVH

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.40
Price
€2.44
GF Value